Variant report

Variant	esv3371041
Chromosome Location	chr8:1710770-1713318
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:676)
CpG islands
(count:489)
Chromatin interactive
region (count:7)
LncRNA
region (count:8)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:676 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr8:1710733-1711272	K562	blood:	n/a	n/a
2	ARID3A	chr8:1712466-1712804	HepG2	liver:	n/a	n/a
3	ATF1	chr8:1711832-1712081	K562	blood:	n/a	n/a
4	ATF2	chr8:1711802-1712124	H1-hESC	embryonic stem cell:	n/a	n/a
5	ATF2	chr8:1711835-1712169	GM12878	blood:	n/a	n/a
6	ATF2	chr8:1711806-1712187	H1-hESC	embryonic stem cell:	n/a	n/a
7	ATF3	chr8:1711826-1712058	K562	blood:	n/a	n/a
8	ATF3	chr8:1711797-1712028	K562	blood:	n/a	n/a
9	ATF3	chr8:1712527-1712754	K562	blood:	n/a	n/a
10	BACH1	chr8:1711786-1712750	H1-hESC	embryonic stem cell:	n/a	n/a
11	BACH1	chr8:1711099-1711111	K562	blood:	n/a	n/a
12	BCL3	chr8:1711088-1711547	A549	lung:	n/a	chr8:1711502-1711515 chr8:1711465-1711478 chr8:1711536-1711545
13	BCL3	chr8:1711834-1712485	A549	lung:	n/a	chr8:1712414-1712427 chr8:1712415-1712428 chr8:1712008-1712017
14	BCL3	chr8:1711828-1712236	A549	lung:	n/a	chr8:1712008-1712017
15	BHLHE40	chr8:1712518-1712852	K562	blood:	n/a	chr8:1712616-1712632
16	BHLHE40	chr8:1711777-1713003	HepG2	liver:	n/a	chr8:1712616-1712632
17	BHLHE40	chr8:1713029-1713280	GM12878	blood:	n/a	n/a
18	BHLHE40	chr8:1711217-1711474	K562	blood:	n/a	n/a
19	BHLHE40	chr8:1711206-1712723	GM12878	blood:	n/a	chr8:1712616-1712632
20	BHLHE40	chr8:1711171-1711562	HepG2	liver:	n/a	n/a
21	BHLHE40	chr8:1711745-1712297	K562	blood:	n/a	n/a
22	BRCA1	chr8:1711994-1712033	HepG2	liver:	n/a	n/a
23	BRCA1	chr8:1712594-1712965	Hela-S3	cervix:	n/a	n/a
24	BRCA1	chr8:1712596-1712713	HepG2	liver:	n/a	n/a
25	BRCA1	chr8:1711351-1711450	Hela-S3	cervix:	n/a	n/a
26	CBX3	chr8:1712536-1712914	K562	blood:	n/a	n/a
27	CCNT2	chr8:1711184-1711536	K562	blood:	n/a	chr8:1711497-1711506
28	CCNT2	chr8:1711764-1713055	K562	blood:	n/a	chr8:1712002-1712011
29	CCNT2	chr8:1710544-1710966	K562	blood:	n/a	n/a
30	CEBPD	chr8:1710593-1711130	K562	blood:	n/a	n/a
31	CEBPD	chr8:1711783-1712163	HepG2	liver:	n/a	n/a
32	CEBPD	chr8:1710617-1711471	K562	blood:	n/a	n/a
33	CHD1	chr8:1713296-1713298	H1-hESC	embryonic stem cell:	n/a	n/a
34	CHD1	chr8:1712493-1712890	GM12878	blood:	n/a	n/a
35	CHD1	chr8:1711076-1711604	GM12878	blood:	n/a	n/a
36	CHD1	chr8:1711287-1711477	H1-hESC	embryonic stem cell:	n/a	n/a
37	CHD1	chr8:1711984-1712293	GM12878	blood:	n/a	chr8:1712003-1712013
38	CHD2	chr8:1712471-1712752	H1-hESC	embryonic stem cell:	n/a	n/a
39	CHD2	chr8:1711960-1712843	K562	blood:	n/a	chr8:1712003-1712013
40	CHD2	chr8:1711912-1712038	H1-hESC	embryonic stem cell:	n/a	chr8:1712003-1712013
41	CHD2	chr8:1712630-1712897	Hela-S3	cervix:	n/a	n/a
42	CHD2	chr8:1711306-1712276	Hela-S3	cervix:	n/a	chr8:1712003-1712013
43	CHD2	chr8:1711083-1711411	GM12878	blood:	n/a	n/a
44	CHD2	chr8:1711895-1712212	HepG2	liver:	n/a	chr8:1712003-1712013
45	CHD2	chr8:1712482-1712857	HepG2	liver:	n/a	n/a
46	CHD2	chr8:1711871-1712221	GM12878	blood:	n/a	chr8:1712003-1712013
47	CREB1	chr8:1712300-1712871	A549	lung:	n/a	n/a
48	CREB1	chr8:1711813-1712028	A549	lung:	n/a	n/a
49	CREB1	chr8:1711787-1712261	A549	lung:	n/a	n/a
50	CTCF	chr8:1712640-1712790	SAEC	small airway:	n/a	chr8:1712670-1712678

(count:489 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:1711235-1711285	NHDF-neo	bronchial:	n/a
2	chr8:1711235-1711285	NHDF-neo	bronchial:	n/a
3	chr8:1712330-1712380	SAEC	small airway:	n/a
4	chr8:1713012-1713062	AG04449	skin:	fetal
5	chr8:1711235-1711285	AoSMC	blood vessel:	n/a
6	chr8:1712007-1712057	Jurkat	blood:	n/a
7	chr8:1711046-1711096	HCF	heart:	n/a
8	chr8:1711433-1711483	GM06990	blood:	n/a
9	chr8:1712170-1712220	HL-60	blood:	n/a
10	chr8:1712170-1712220	PFSK-1	brain:	n/a
11	chr8:1712330-1712380	AG04450	lung:	fetal
12	chr8:1712007-1712057	LNCaP	prostate:	n/a
13	chr8:1712271-1712321	SK-N-SH	brain:	n/a
14	chr8:1712170-1712220	HNPCEpiC	eye:	n/a
15	chr8:1713012-1713062	BE2_C	brain:	n/a
16	chr8:1712271-1712321	HEK293	kidney:	embryo
17	chr8:1712170-1712220	MCF10A-Er-Src	breast:	n/a
18	chr8:1713012-1713062	AG09309	skin:	n/a
19	chr8:1712271-1712321	GM12892	blood:	n/a
20	chr8:1711046-1711096	GM06990	blood:	n/a
21	chr8:1712170-1712220	PANC-1	pancreas:	n/a
22	chr8:1711433-1711483	MCF10A-Er-Src	breast:	n/a
23	chr8:1711235-1711285	SKMC	muscle:	n/a
24	chr8:1711046-1711096	ProgFib	skin:	n/a
25	chr8:1712330-1712380	T-47D	breast:	n/a
26	chr8:1712007-1712057	H1-hESC	embryonic stem cell:	embryo
27	chr8:1712170-1712220	HIPEpiC	eye:	n/a
28	chr8:1711235-1711285	HPAEpiC	pulmonary alveolar:	n/a
29	chr8:1711433-1711483	CMK	blood:	n/a
30	chr8:1712271-1712321	AG09319	gingival:	n/a
31	chr8:1712271-1712321	PANC-1	pancreas:	n/a
32	chr8:1711433-1711483	BE2_C	brain:	n/a
33	chr8:1711235-1711285	ovcar-3	ovarian:	n/a
34	chr8:1712330-1712380	CMK	blood:	n/a
35	chr8:1712007-1712057	BJ	skin:	n/a
36	chr8:1713012-1713062	PrEC	prostate:	n/a
37	chr8:1713012-1713062	AG04450	lung:	fetal
38	chr8:1711235-1711285	HCT-116	colon:	n/a
39	chr8:1711433-1711483	HRPEpiC	eye:	n/a
40	chr8:1712330-1712380	GM12892	blood:	n/a
41	chr8:1711433-1711483	HUVEC	blood vessel:	n/a
42	chr8:1711046-1711096	HL-60	blood:	n/a
43	chr8:1712007-1712057	HEK293	kidney:	embryo
44	chr8:1712271-1712321	HCT-116	colon:	n/a
45	chr8:1711433-1711483	SK-N-SH	brain:	n/a
46	chr8:1713012-1713062	HPAEpiC	pulmonary alveolar:	n/a
47	chr8:1713012-1713062	NH-A	brain:	n/a
48	chr8:1712330-1712380	BE2_C	brain:	n/a
49	chr8:1712271-1712321	Hepatocyte	liver:	n/a
50	chr8:1712271-1712321	T-47D	breast:	n/a

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr8:1708066..1710813-chr8:1745165..1747310,2	MCF-7	breast:
2	chr8:1712944..1715681-chr8:1734053..1736692,2	K562	blood:
3	chr8:1711111..1712724-chr8:1772703..1775383,2	MCF-7	breast:
4	chr8:1702392..1708895-chr8:1709221..1714010,17	MCF-7	breast:
5	chr8:1710901..1715165-chr8:1763143..1767602,4	K562	blood:
6	chr8:1676916..1679793-chr8:1711386..1713857,2	K562	blood:
7	chr17:38219023..38219851-chr8:1710924..1711761,2	Hela-S3	cervix:

(count:8 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ERICH1-7	chr8:1709431-1711094	NONHSAT124680
2	lnc-ERICH1-7	chr8:1712600-1712716	NONHSAT124680
3	lnc-ERICH1-7	chr8:1712600-1712668	ENSG00000253982.1
4	lnc-ERICH1-7	chr8:1710247-1711094	ENSG00000253982.1
5	lnc-ERICH1-7	chr8:1710156-1711094	ENSG00000253982.1
6	lnc-ERICH1-7	chr8:1712467-1712500	NONHSAT124681
7	lnc-ERICH1-7	chr8:1712467-1712505	ENSG00000253982.1
8	lnc-ERICH1-7	chr8:1709431-1711094	NONHSAT124681

No data

Variant related genes	Relation type
CLN8	TF binding region
ENSG00000253982	TF binding region
CLN8	CpG island
ENSG00000253982	CpG island
ENSG00000207826	chromatin interactions
ENSG00000182372	chromatin interactions
ENSG00000254265	chromatin interactions
ENSG00000126351	chromatin interactions
ENSG00000104728	chromatin interactions

Extended variants
information (count: 106 )
Associated
traits (count: 116 )

Variant overlapped rSNPs/rCNVs (count:106 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs540259671	chr8:1710775-1710776	Active TSS Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
2	rs560150316	chr8:1710802-1710803	Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
3	rs369862239	chr8:1710963-1710964	Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
4	rs9022	chr8:1710977-1710978	Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region lncRNA	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
5	rs550243174	chr8:1711000-1711001	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
6	rs571888478	chr8:1711021-1711022	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
7	rs542935961	chr8:1711023-1711024	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
8	rs539286447	chr8:1711062-1711063	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
9	rs531821171	chr8:1711063-1711064	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
10	rs138897814	chr8:1711100-1711101	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs180781092	chr8:1711102-1711103	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs2293977	chr8:1711121-1711122	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
13	rs547059900	chr8:1711131-1711132	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
14	rs112380790	chr8:1711152-1711153	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
15	rs149262569	chr8:1711163-1711164	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs111755266	chr8:1711167-1711168	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
17	rs550111772	chr8:1711211-1711212	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
18	rs536749151	chr8:1711218-1711219	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
19	rs369450577	chr8:1711239-1711240	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs569823244	chr8:1711256-1711257	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs185063229	chr8:1711259-1711260	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs13540	chr8:1711275-1711276	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
23	rs376101997	chr8:1711303-1711304	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
24	rs571635692	chr8:1711324-1711325	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs576390674	chr8:1711365-1711366	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
26	rs377232377	chr8:1711384-1711385	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
27	rs573714262	chr8:1711415-1711416	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
28	rs542872464	chr8:1711426-1711427	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
29	rs556442190	chr8:1711448-1711449	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
30	rs189525069	chr8:1711533-1711534	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	mRNA abundance
31	rs181966608	chr8:1711546-1711547	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
32	rs562405797	chr8:1711555-1711556	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
33	rs576080371	chr8:1711558-1711559	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
34	rs576717866	chr8:1711706-1711707	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
35	rs377333932	chr8:1711810-1711811	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
36	rs545261933	chr8:1711862-1711863	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
37	rs565506859	chr8:1711867-1711868	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
38	rs527372535	chr8:1711887-1711888	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
39	rs544824476	chr8:1711890-1711891	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
40	rs71209699	chr8:1711895-1711896	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
41	rs541147217	chr8:1711902-1711903	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
42	rs565077918	chr8:1711909-1711910	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
43	rs71499040	chr8:1711918-1711919	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
44	rs529719463	chr8:1711939-1711940	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
45	rs549851500	chr8:1711954-1711955	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
46	rs569845444	chr8:1711965-1711966	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
47	rs540885498	chr8:1712047-1712048	Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
48	rs113428006	chr8:1712049-1712050	Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs552065192	chr8:1712087-1712088	Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs551816950	chr8:1712126-1712127	Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:116)

Disease	PMID	Source
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Congenital diaphragmatic hernia	21341218	CNVD
Cancer	18840272	CNVD
Pilocytic astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	16573809	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
abnormal development	18461090	CNVD
Crohn''s disease	19220326	CNVD
Psoriasis	19220326	CNVD
Prostate cancer	21965145	CNVD
Prostate cancer	18515986	CNVD
Chronic obstructive pulmonary disease	20378733	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	17603634	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Ovarian cancer	20844748	CNVD
Cervical cancer	17311676	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Schizophrenia	20877625	CNVD
Disorders of sex development	21048976	CNVD
Colorectal cancer	16272173	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	17001317	CNVD
Thyroid cancer	19087340	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Cancer	20164919	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
Ductal carcinoma	22052326	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Epilepsy	22083797	CNVD
Acute myeloid leukemia	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Breast cancer	20932292	CNVD
Congenital diaphragmatic hernia	21064195	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Ependymoma	20639864	CNVD
Ovarian cancer	22355333	CNVD
Schizophrenia	23813976	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:482 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:1704000-1710800	Weak transcription	H1 Cell Line	embryonic stem cell
2	chr8:1707400-1710800	Enhancers	Fetal Thymus	thymus
3	chr8:1707800-1710800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
4	chr8:1707800-1710800	Weak transcription	Right Ventricle	heart
5	chr8:1708400-1710800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
6	chr8:1708400-1710800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
7	chr8:1708600-1710800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr8:1709000-1710800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
9	chr8:1709000-1710800	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
10	chr8:1709000-1710800	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
11	chr8:1709200-1710800	Weak transcription	Pancreas	Pancrea
12	chr8:1710000-1710800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
13	chr8:1710200-1710800	Enhancers	Primary T cells fromperipheralblood	blood
14	chr8:1710200-1710800	Enhancers	Fetal Muscle Leg	muscle
15	chr8:1710400-1710800	Genic enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
16	chr8:1710400-1710800	Enhancers	Breast Myoepithelial Primary Cells	Breast
17	chr8:1710400-1710800	Enhancers	Primary T killer memory cells from peripheral blood	blood
18	chr8:1710400-1710800	Enhancers	Left Ventricle	heart
19	chr8:1710400-1711200	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
20	chr8:1710400-1711200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
21	chr8:1710400-1711200	Transcr. at gene 5' and 3'	A549	lung
22	chr8:1710400-1711400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
23	chr8:1710400-1712200	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
24	chr8:1710600-1710800	Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr8:1710600-1710800	Flanking Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
26	chr8:1710600-1710800	Enhancers	iPS-15b Cell Line	embryonic stem cell
27	chr8:1710600-1710800	Enhancers	Primary B cells from cord blood	blood
28	chr8:1710600-1710800	Enhancers	Primary B cells from peripheral blood	blood
29	chr8:1710600-1710800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
30	chr8:1710600-1710800	Enhancers	Primary T helper naive cells from peripheral blood	blood
31	chr8:1710600-1710800	Enhancers	Primary T regulatory cells fromperipheralblood	blood
32	chr8:1710600-1710800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
33	chr8:1710600-1710800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
34	chr8:1710600-1710800	Active TSS	Cortex derived primary cultured neurospheres	brain
35	chr8:1710600-1710800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
36	chr8:1710600-1710800	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
37	chr8:1710600-1710800	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
38	chr8:1710600-1710800	Enhancers	Brain Angular Gyrus	brain
39	chr8:1710600-1710800	Active TSS	Brain Anterior Caudate	brain
40	chr8:1710600-1710800	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
41	chr8:1710600-1710800	Enhancers	Colon Smooth Muscle	Colon
42	chr8:1710600-1710800	Enhancers	Duodenum Mucosa	Duodenum
43	chr8:1710600-1710800	Flanking Active TSS	Duodenum Smooth Muscle	Duodenum
44	chr8:1710600-1710800	Weak transcription	Esophagus	oesophagus
45	chr8:1710600-1710800	Enhancers	Fetal Brain Male	brain
46	chr8:1710600-1710800	Enhancers	Fetal Heart	heart
47	chr8:1710600-1710800	Flanking Active TSS	Fetal Intestine Large	intestine
48	chr8:1710600-1710800	Enhancers	Fetal Intestine Small	intestine
49	chr8:1710600-1710800	Flanking Active TSS	Fetal Lung	lung
50	chr8:1710600-1710800	Enhancers	Placenta	Placenta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links